Cargando…

CONSORT in China: past development and future direction

The Consolidated Standards of Reporting Trials (CONSORT) Statement was published in 1996, and first introduced to China in 2001. Although CONSORT has been widely accepted in high-quality international journals, we still need to have more investigation on how many Chinese journals have adopted the CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Tian-Jiao, Leng, Hou-Fu, Zhong, Linda LD, Wu, Tai-Xiang, Bian, Zhao-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467063/
https://www.ncbi.nlm.nih.gov/pubmed/26026311
http://dx.doi.org/10.1186/s13063-015-0769-z
_version_ 1782376313736134656
author Song, Tian-Jiao
Leng, Hou-Fu
Zhong, Linda LD
Wu, Tai-Xiang
Bian, Zhao-Xiang
author_facet Song, Tian-Jiao
Leng, Hou-Fu
Zhong, Linda LD
Wu, Tai-Xiang
Bian, Zhao-Xiang
author_sort Song, Tian-Jiao
collection PubMed
description The Consolidated Standards of Reporting Trials (CONSORT) Statement was published in 1996, and first introduced to China in 2001. Although CONSORT has been widely accepted in high-quality international journals, we still need to have more investigation on how many Chinese journals have adopted the CONSORT Statement, and whether the quality of reporting has improved. A systematic search of the “Instructions to authors” in all Chinese medical journals in China Academic Journals (CAJ) Full-text Database was conducted up to February 2012 and only 7 journals officially listed the requirements of the CONSORT Statement. The research articles about randomized controlled trials (RCTs) published in 2002, 2004, 2006, 2008, and 2010 from journals which had specifically adopted the CONSORT Statement, and from 30 top journals based on the Chinese Science Citation Index (CSCI) 2011 as the control group, were identified. The quality of both cohorts of articles was assessed using the revised CONSORT Checklist and Jadad scale. A total of 1221 Chinese medical journals was identified. Only seven journals stated clearly in the “Instructions to authors” that authors should adopt the CONSORT requirement in the clinical trial paper. None of these journals is among the control group in the CSCI 2011. In the selected years, a total of 171 articles from 7 journals which had adopted CONSORT and 232 articles in the control were identified as including RCT trials. The average scores according to the revised CONSORT Checklist were 29.47 for the CONSORT-adopting journals and 25.57 for the control group; while the average scores based on the Jadad scale were 2.53 for CONSORT-adopting journals and 1.97 for the control group. Few journals among Chinese medical journals have adopted the CONSORT Statement. The overall quality of RCT reports in the 7 journals which have adopted CONSORT was better than those in the top 30 journals which have not adopteded CONSORT. The quality of RCT reports in Chinese journals needs further improvement, and the CONSORT Statement could be a very helpful guideline.
format Online
Article
Text
id pubmed-4467063
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44670632015-06-16 CONSORT in China: past development and future direction Song, Tian-Jiao Leng, Hou-Fu Zhong, Linda LD Wu, Tai-Xiang Bian, Zhao-Xiang Trials Review The Consolidated Standards of Reporting Trials (CONSORT) Statement was published in 1996, and first introduced to China in 2001. Although CONSORT has been widely accepted in high-quality international journals, we still need to have more investigation on how many Chinese journals have adopted the CONSORT Statement, and whether the quality of reporting has improved. A systematic search of the “Instructions to authors” in all Chinese medical journals in China Academic Journals (CAJ) Full-text Database was conducted up to February 2012 and only 7 journals officially listed the requirements of the CONSORT Statement. The research articles about randomized controlled trials (RCTs) published in 2002, 2004, 2006, 2008, and 2010 from journals which had specifically adopted the CONSORT Statement, and from 30 top journals based on the Chinese Science Citation Index (CSCI) 2011 as the control group, were identified. The quality of both cohorts of articles was assessed using the revised CONSORT Checklist and Jadad scale. A total of 1221 Chinese medical journals was identified. Only seven journals stated clearly in the “Instructions to authors” that authors should adopt the CONSORT requirement in the clinical trial paper. None of these journals is among the control group in the CSCI 2011. In the selected years, a total of 171 articles from 7 journals which had adopted CONSORT and 232 articles in the control were identified as including RCT trials. The average scores according to the revised CONSORT Checklist were 29.47 for the CONSORT-adopting journals and 25.57 for the control group; while the average scores based on the Jadad scale were 2.53 for CONSORT-adopting journals and 1.97 for the control group. Few journals among Chinese medical journals have adopted the CONSORT Statement. The overall quality of RCT reports in the 7 journals which have adopted CONSORT was better than those in the top 30 journals which have not adopteded CONSORT. The quality of RCT reports in Chinese journals needs further improvement, and the CONSORT Statement could be a very helpful guideline. BioMed Central 2015-06-01 /pmc/articles/PMC4467063/ /pubmed/26026311 http://dx.doi.org/10.1186/s13063-015-0769-z Text en © Song et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Song, Tian-Jiao
Leng, Hou-Fu
Zhong, Linda LD
Wu, Tai-Xiang
Bian, Zhao-Xiang
CONSORT in China: past development and future direction
title CONSORT in China: past development and future direction
title_full CONSORT in China: past development and future direction
title_fullStr CONSORT in China: past development and future direction
title_full_unstemmed CONSORT in China: past development and future direction
title_short CONSORT in China: past development and future direction
title_sort consort in china: past development and future direction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467063/
https://www.ncbi.nlm.nih.gov/pubmed/26026311
http://dx.doi.org/10.1186/s13063-015-0769-z
work_keys_str_mv AT songtianjiao consortinchinapastdevelopmentandfuturedirection
AT lenghoufu consortinchinapastdevelopmentandfuturedirection
AT zhonglindald consortinchinapastdevelopmentandfuturedirection
AT wutaixiang consortinchinapastdevelopmentandfuturedirection
AT bianzhaoxiang consortinchinapastdevelopmentandfuturedirection